An open‐label pilot study of N‐acetylcysteine for skin‐picking in Prader–Willi syndrome

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Medical Genetics. Part A

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ajmg.a.36306PMID 24311388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats

  2013cited by this paper
• Glutathione and its dependent enzymes’ modulatory responses to toxic metals and metalloids in fish—a review

  2013cited by this paper
• Effectiveness of Naltrexone for Treating Pathologic Skin Picking Behavior in an Adolescent with Prader–Willi Syndrome

  2012cited by this paper
• Investigation of Cortical Glutamate–Glutamine and γ-Aminobutyric Acid in Obsessive–Compulsive Disorder by Proton Magnetic Resonance Spectroscopy

  2012cited by this paper
• A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.

  2012cited by this paper
• N-acetyl-L-cysteine inhibits marble-burying behavior in mice.

  2012cited by this paper
• N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study

  2012cited by this paper
• N-acetylcysteine in the Treatment of Trichotillomania

  2012cited by this paper
• N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking

  2012cited by this paper
• N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia.

  2012cited by this paper
• Pulmonary , gastrointestinal and urogenital pharmacology N-acetylcysteine improves redox status , mitochondrial dysfunction , mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice

  2012cited by this paper
• N-acetylcysteine reverses existing cognitive impairment and increased oxidative stress in glutamate transporter type 3 deficient mice.

  2012cited by this paper
• N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals

  2012cited by this paper
• Proteomic analysis of brain proteins in APP/PS‐1 human double mutant knock‐in mice with increasing amyloid β‐peptide deposition: Insights into the effects of in vivo treatment with N‐acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease

  2011cited by this paper
• Animal models of obsessive compulsive disorder: recent findings and future directions

  2011cited by this paper
• The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.

  2011cited by this paper
• A Preliminary Analysis of the Phenomenology of Skin-picking in Prader-Willi Syndrome

  2010influential reference
• Prader–Willi syndrome

  2009cited by this paper
• N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.

  2009cited by this paper
• Array comparative genomic hybridization (aCGH) analysis in Prader–Willi syndrome

  2008influential reference
• N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.

  2007cited by this paper
• Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome.

  2002cited by this paper
• Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations.

  1999cited by this paper
• Obsessions and compulsions in Prader-Willi syndrome.

  1996cited by this paper
• Prader-Willi syndrome

  1989cited by this paper

• Pediatric Psychodermatology: Advancing Therapy through Integrated Care.

  2026cites this paper
• N-Acetylcysteine (NAC) for Trichotillomania and Excoriation Disorder: An Overview.

  2025cites this paper
• Exploring the Role of N-Acetylcysteine in Pediatric Trichotillomania: A Review of Safety, Efficacy, and Therapeutic Potential amid Controversy

  2025cites this paper
• N-acetylcysteine in skin picking disorders

  2025cites this paper
• N-acetylcysteine for Trichotemnomania in an Adult Female With Williams Syndrome

  2024cites this paper
• Prader–Willi syndrome: guidance for children and transition into adulthood

  2024cites this paper
• Obsesif Kompulsif ve İlişkili Bozuklukların Tedavisinde Glutamaterjik Modülatörlerin Rolü

  2023cites this paper
• The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

  2022cites this paper
• “N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review”

  2022cites this paper
• The Potential of N-acetyl Cysteine in Behavioral Addictions and Related Compulsive and Impulsive Behaviors and Disorders: a Scoping Review

  2022cites this paper
• Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China

  2022cites this paper
• The Potential of N-Acetylcysteine for Treatment of Trichotillomania, Excoriation Disorder, Onychophagia, and Onychotillomania: An Updated Literature Review

  2022cites this paper
• Pediatric skin picking disorder: A review of management

  2022cites this paper
• N‐acetylcysteine as a new prominent approach for treating psychiatric disorders

  2021influential citation
• Review of the diagnosis and management of pediatric psychodermatologic conditions: Part I

  2021cites this paper
• N‐Acetylcysteine provides limited efficacy as treatment option for skin picking in Prader–Willi syndrome

  2021cites this paper
• Hospital outcomes in pediatric patients with Prader-Willi syndrome (PWS) undergoing orthopedic surgery: A 12-year analysis of national trends in surgical management and inpatient hospital outcomes.

  2021cites this paper
• Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice Experiment

  2021cites this paper
• Dermatillomania: Strategies for Developing Protective Biomaterials/Cloth

  2021cites this paper
• A systematic review of N‐acetylcysteine for treatment of acne vulgaris and acne‐related associations and consequences: Focus on clinical studies

  2021cites this paper
• Prader-Willi syndrome: molecular mechanism and epigenetic therapy.

  2020cites this paper
• The RDoC approach for translational psychiatry: Could a genetic disorder with psychiatric symptoms help fill the matrix? the example of Prader–Willi syndrome

  2020cites this paper
• Skin Picking in People with Prader–Willi Syndrome: Phenomenology and Management

  2020cites this paper
• Efficacy and safety of N-acetylcysteine as add-on therapy in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis

  2020cites this paper
• Developing an understanding of skin picking in people with Prader-Willi syndrome: a structured literature review and re-analysis of existing data.

  2020cites this paper
• Skin picking disorder in 97 Italian and Spanish Cri du chat patients

  2019cites this paper
• Alternative Treatments for Obsessive-Compulsive Disorder: Nutraceuticals and Lifestyle Interventions

  2019cites this paper
• A review of N‐acetylcysteine in the treatment of grooming disorders

  2019cites this paper
• A multidisciplinary approach to the clinical management of Prader–Willi syndrome

  2019cites this paper
• Guanfacine Extended Release for the Reduction of Aggression, Attention-Deficit/Hyperactivity Disorder Symptoms, and Self-Injurious Behavior in Prader-Willi Syndrome—A Retrospective Cohort Study

  2019cites this paper
• Psychopathological disorders in Prader-Willi syndrome.

  2019cites this paper
• Repetitive Behaviors Treated With N-Acetylcysteine: Case Series.

  2019cites this paper
• The Potential Uses of N-acetylcysteine in Dermatology: A Review.

  2019cites this paper
• Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update

  2019cites this paper
• N‐Acetylcysteine in psychodermatological disorders

  2019cites this paper
• Psychopathological disorders in Prader–Willi syndrome

  2019cites this paper
• Application of N-Acetylcysteine in Psychiatric Disorders

  2018cites this paper
• Wide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriée at a Swiss tertiary hospital

  2018cites this paper
• [Neuropsychiatric aspects of Prader-Willi syndrome – a review].

  2018cites this paper
• N-Acetylcysteine Blocks Serotonin 1B Agonist-Induced OCD-Related Behavior in Mice

  2018cites this paper
• Prader-Willi Syndrome (PWS)

  2018cites this paper
• N-acetylcysteine in dermatology

  2018cites this paper
• N‐acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta‐analysis

  2017cites this paper
• in the Treatment of

  2017cites this paper
• Self-Inflicted Lesions in Dermatology: A Management and TherapeuticApproach - A Position Paper From the European Society for Derma-tology and Psychiatry.

  2017cites this paper
• N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects

  2017cites this paper
• Certainty of genuine treatment increases drug responses among intellectually disabled patients

  2017cites this paper
• A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder.

  2016cites this paper
• The Developmental Trajectory of Self-Injurious Behaviours in Individuals with Prader Willi Syndrome, Autism Spectrum Disorder and Intellectual Disability

  2016cites this paper
• Aripiprazole in the Treatment of Obsessive Compulsive Disorder and Aggressive Behaviors in a Child With Prader Willi Syndrome: A Case Report.

  2016cites this paper
• Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.

  2016cites this paper
• A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models

  2016cites this paper
• Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.

  2016cites this paper
• Prader-Willi syndrome mental health research strategy workshop proceedings: the state of the science and future directions

  2016cites this paper
• N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial.

  2016cites this paper
• Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

  2015cites this paper
• Antioxidant Therapies for Ulcerative Dermatitis: A Potential Model for Skin Picking Disorder

  2015cites this paper
• Cognitive and behavioural aspects of Prader–Willi syndrome

  2015cites this paper
• A disease specific questionnaire for assessing behavior in individuals with Prader-Willi syndrome.

  2015cites this paper
• Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature

  2015cites this paper
• linical trials of N-acetylcysteine in psychiatry and neurology : systematic

  2015cites this paper
• N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review

  2015cites this paper
• Glutamatergic dysfunction in skin-picking disorder: treatment of a pediatric patient with N-acetylcysteine.

  2014cites this paper
• PRADER–WILLI SYNDROME

  2005cites this paper
• Prader-Willi syndrome

  1989cites this paper
• Psychology Research and Behavior Management Dovepress a Selective Review of Glutamate Pharmacological Therapy in Obsessive–compulsive and Related Disorders

  year unknowncites this paper
• Endocrinología, Diabetes y Nutrición

  year unknowncites this paper